Pediatric versus adult drug trials for conditions with high pediatric disease burden

Pediatrics

Volumn 130, Issue 2, 2012, Pages 285-292

  Bourgeois, Florence T ^a,b   Murthy, Srinivas ^c   Pinto, Catia ^d   Olson, Karen L ^a,b   Ioannidis, John P A ^e   Mandl, Kenneth D ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d Hospital Center of Central Lisbon   (Portugal)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; Evidence based medicine; Medication use; Pediatrics; Research subjects

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ADULTHOOD; ARTICLE; ASTHMA; BIPOLAR DISORDER; CHILD; CHILDHOOD; CHILDHOOD DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DEPRESSION; DEVELOPING COUNTRY; DIARRHEA; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; FUNDING; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HUMAN; INCOME; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALARIA; MIGRAINE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLICATION; REGISTRATION; SCHIZOPHRENIA;

EID: 84864497515     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-0139     Document Type: Article

References (44)

1. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164(9):552-558 (Pubitemid 41225059)
2. Shah SS, Hall M, Goodman DM, et al. Offlabel drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161(3): 282-290 (Pubitemid 46364332)
3. Caldwell PH, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet. 2004; 364(9436):803-811 (Pubitemid 39165102)
4. Smyth RL, Weindling AM. Research in children: ethical and scientific aspects. Lancet. 1999;354(suppl 2):SII21-SII24
5. Steinbrook R. Testing medications in children. N Engl J Med. 2002;347(18):1462-1470 (Pubitemid 35239728)
6. Lindkvist J, Airaksinen M, Kaukonen AM, Klaukka T, Hoppu K. Evolution of paediatric off-label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994-2007. Br J Clin Pharmacol. 2011;71(6):929-935
7. Waller DG. Off-label and unlicensed prescribing for children: have we made any progress? Br J Clin Pharmacol. 2007;64(1): 1-2 (Pubitemid 46934428)
8. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology - drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157-1167 (Pubitemid 37122329)
9. Feder HM Jr, Osier C, Maderazo EG. Chloramphenicol: a review of its use in clinical practice. Rev Infect Dis. 1981;3(3):479-491
10. Hatch DJ. Propofol-infusion syndrome in children. Lancet. 1999;353(9159):1117-1118 (Pubitemid 29155201)
11. Hamm MP, Hartling L, Milne A, et al. A descriptive analysis of a representative sample of pediatric randomized controlled trials published in 2007. BMC Pediatr. 2010;10:96
12. Cohen E, Goldman RD, Ragone A, et al. Child vs adult randomized controlled trials in specialist journals: a citation analysis of trends, 1985-2005. Arch Pediatr Adolesc Med. 2010;164(3):283-288
13. Martinez-Castaldi C, Silverstein M, Bauchner H. Child versus adult research: the gap in high-quality study design. Pediatrics. 2008; 122(1):52-57
14. Cohen E, Uleryk E, Jasuja M, Parkin PC. An absence of pediatric randomized controlled trials in general medical journals, 1985-2004. J Clin Epidemiol. 2007;60(2):118-123 (Pubitemid 46039874)
15. Anderson M, Choonara I. A systematic review of safety monitoring and drug toxicity in published randomised controlled trials of antiepileptic drugs in children over a 10-year period. Arch Dis Child. 2010;95(9): 731-738
16. Aripin KN, Choonara I, Sammons HM. A systematic review of paediatric randomised controlled drug trials published in 2007. Arch Dis Child. 2010;95(6):469-473
17. Nor Aripin KN, Sammons HM, Choonara I. Published pediatric randomized drug trials in developing countries, 1996-2002. Paediatr Drugs. 2010;12(2):99-103
18. World Health Organization. The global burden of disease: 2004 update. Geneva, Switzerland: World Health Organization; 2008. Available at: www.who.int/evidence/ bod. Accessed May 5, 2012
19. Gross CP, Anderson GF, Powe NR. The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med. 1999;340(24):1881-1887 (Pubitemid 29272669)
20. Isaakidis P, Swingler GH, Pienaar E, Volmink J, Ioannidis JP. Relation between burden of disease and randomised evidence in sub- Saharan Africa: survey of research. BMJ. 2002;324(7339):702
21. National Institutes of Health. ClinicalTrials. gov. Available at: www.clinicaltrials.gov. Accessed May 5, 2012
22. Estellat C, Ravaud P. Lack of head-to-head trials and fair control arms: randomized controlled trials of biologic treatment for rheumatoid arthritis. Arch Intern Med. 2012; 172(3):237-244
23. Viergever RF, Ghersi D. The quality of registration of clinical trials. PLoS ONE. 2011;6 (2):e14701
24. Bourgeois FT, Murthy S, Mandl KD. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med. 2010;153 (3):158-166
25. Thomson D, Hartling L, Cohen E, Vandermeer B, Tjosvold L, Klassen TP. Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published 1948-2006. PLoS ONE. 2010;5(9):e13106
26. Institute of Medicine. Learning what works best: the nation's need for evidence on comparative effectiveness in health care. 2007. Available at: www.iom.edu/~/media/Files/Activity%20Files/Quality/VSRT/ ComparativeEffectivenessWhitePaperF. ashx. Accessed May 5, 2012
27. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database - update and key issues. N Engl J Med. 2011; 364(9):852-860
28. Lee K, Bacchetti P, Sim I. Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med. 2008;5(9):e191
29. Ioannidis JP. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA. 1998;279(4):281-286
30. Coté CJ, Kauffman RE, Troendle GJ, Lambert GH. Is the "therapeutic orphan" about to be adopted? Pediatrics. 1996;98(1):118-123
31. Roberts R, Rodriguez W, Murphy D, Crescenzi T. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA. 2003;290(7):905-911 (Pubitemid 37430462)
32. Specific Requirements on Content and Format of Labeling for Human Prescription Drugs; Revision of "Pediatric Use" Subsection in the Labeling; Final Rule. Available at: www.gpo.gov/fdsys/pkg/FR-1994-12-13/html/94- 30238.htm. Accessed May 5, 2012
33. Best Pharmaceuticals for Children Act. Pub L No. Best Pharmaceuticals for Children Act of 2007. Title V of Pub L No 110-85. 2007
34. Pediatric Research Equity Act. Pub L No. Pediatric Research Equity Act of 2007. Title IV of 110-85. 2007
35. Choonara I. Regulation of drugs for children in Europe. BMJ. 2007;335(7632):1221-1222
36. Watts G. WHO launches campaign to make drugs safer for children. BMJ. 2007;335 (7632):1227
37. Berger E. Ghostwriters, data manipulation and dollar diplomacy: how drug companies pull the strings in clinical research. Ann Emerg Med. 2008;52(2):137-139
38. Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ. 2004;170(4):477-480 (Pubitemid 38293642)
39. Sammons HM, Choonara I. Clinical trials of medication in children, 1996-2002. Eur J Clin Pharmacol. 2005;61(2):165-167 (Pubitemid 40674751)
40. Trouiller P, Olliaro PL. Drug development output: what proportion for tropical diseases? Lancet. 1999;354(9173):164 (Pubitemid 29313168)
41. Wolffers I, Adjei S, van der Drift R. Health research in the tropics. Lancet. 1998;351 (9116):1652-1654 (Pubitemid 28252190)
42. Chan AW. Bias, spin, and misreporting: time for full access to trial protocols and results. PLoS Med. 2008;5(11):e230
43. Lassere M, Johnson K. The power of the protocol. Lancet. 2002;360(9346):1620-1622 (Pubitemid 35379731)
44. Contopoulos-Ioannidis DG, Baltogianni MS, Ioannidis JP. Comparative effectiveness of medical interventions in adults versus children. J Pediatr. 2010;157(2):322-330.e17